Human Papillomavirus (HPV) Vaccines as an Option for Preventing Cervical Malignancies: (How) Effective and Safe?

Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions

2007 • 2,003 citations

NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN

1998 • 1,885 citations

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

2007 • 1,829 citations

Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

2007 • 1,820 citations

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

2004 • 1,624 citations

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

2009 • 1,580 citations

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis

2007 • 1,558 citations

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

2003 • 1,535 citations

Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings

2010 • 1,431 citations

NATURAL HISTORY OF CERVICAL INTRAEPITHELIAL NEOPLASIA

1967 • 1,370 citations

A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned

2011 • 1,318 citations

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis

2005 • 1,063 citations

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study

2008 • 1,039 citations

‘ASIA’ – Autoimmune/inflammatory syndrome induced by adjuvants

2010 • 918 citations

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

2006 • 803 citations

Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer

1999 • 668 citations

The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women

1998 • 566 citations

Cervical cancer and use of hormonal contraceptives: a systematic review

2003 • 518 citations

Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine

2009 • 461 citations

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial

2009 • 373 citations

Health and Economic Implications of HPV Vaccination in the United States

2008 • 362 citations

External Genital Warts: Diagnosis, Treatment, and Prevention

2002 • 355 citations

Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle

2001 • 353 citations

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 years

2009 • 347 citations

Human Papillomavirus Infection and Time to Progression and Regression of Cervical Intraepithelial Neoplasia

2003 • 331 citations

Determinants of Clearance of Human Papillomavirus Infections in Colombian Women with Normal Cytology: A Population-based, 5-Year Follow-up Study

2003 • 310 citations

Adjuvants and autoimmunity

2009 • 264 citations

Rate of and Risks for Regression of Cervical Intraepithelial Neoplasia 2 in Adolescents and Young Women

2010 • 246 citations

Vaccines and autoimmunity

2009 • 242 citations

What have we learnt from Vioxx?

2007 • 237 citations

Industry-Sponsored Clinical Research

2008 • 230 citations

Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study

2003 • 223 citations

CIN2 Is a Much Less Reproducible and Less Valid Diagnosis than CIN3

2007 • 216 citations

The Relationship of Community Biopsy-Diagnosed Cervical Intraepithelial Neoplasia Grade 2 to the Quality Control Pathology-Reviewed Diagnoses

2007 • 195 citations

Chapter 4: Genital Tract Infections, Cervical Inflammation, and Antioxidant Nutrients--Assessing Their Roles as Human Papillomavirus Cofactors

2003 • 191 citations

Aluminum Vaccine Adjuvants: Are they Safe?

2011 • 188 citations

Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine

2011 • 188 citations

The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada

2007 • 181 citations

Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration

2009 • 169 citations

Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women

2010 • 164 citations

Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines

2008 • 149 citations

Central nervous system disease in patients with macrophagic myofasciitis

2001 • 142 citations

Vaccine-induced Autoimmunity

1996 • 134 citations

Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India

2008 • 127 citations

CNS demyelination and quadrivalent HPV vaccination

2008 • 119 citations

A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome

2008 • 117 citations

Anaphylaxis following quadrivalent human papillomavirus vaccination

2008 • 117 citations

Influenza vaccination: policy versus evidence

2006 • 112 citations

Annual report: surveillance of adverse events following immunisation in Australia, 2004.

2005 • 112 citations

Aluminum Adjuvant Linked to Gulf War Illness Induces Motor Neuron Death in Mice

2006 • 109 citations

Marketing HPV Vaccine

2009 • 103 citations

Do aluminum vaccine adjuvants contribute to the rising prevalence of autism?

2011 • 103 citations

Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland

2003 • 101 citations

Human papillomavirus, vaccines and women's health: questions and cautions

2007 • 101 citations

Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations

2012 • 93 citations

Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction

2009 • 89 citations

Systemic lupus erythematosus following HPV immunization or infection?

2012 • 89 citations

Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: a cost-effectiveness analysis

2008 • 87 citations

Practices of Participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology, 2006

2010 • 84 citations

Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010, on the basis of relative survival analysis. A collaborative study of the five Nordic Cancer Registries.

1995 • 80 citations

Guillain–Barré syndrome after Gardasil vaccination: Data from Vaccine Adverse Event Reporting System 2006–2009

2010 • 76 citations

HPV vaccination in France: Uptake, costs and issues for the National Health Insurance

2011 • 75 citations

Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands

2009 • 74 citations

Prophylactic HPV vaccines: current knowledge of impact on gynecologic premalignancies.

2010 • 68 citations

Human papillomavirus (HPV) vaccine policy and evidence-based medicine: Are they at odds?

2011 • 59 citations

Multifactorial etiology of cervical cancer: a hypothesis.

2005 • 58 citations

A Fall-off in Cervical Screening Coverage of Younger Women in Developed Countries

2010 • 54 citations

The effect of stopping smoking on cervical Langerhans'cells and lymphocytes

2001 • 49 citations

Cost‐effectiveness of human papillomavirus vaccination and cervical cancer screening in Thailand

2011 • 47 citations

Pharmaceutical Companies’ Role in State Vaccination Policymaking: The Case of Human Papillomavirus Vaccination

2012 • 47 citations

Beyond Human Papillomavirus: The Cervix, Exogenous Secondary Factors, and the Development of Cervical Precancer and Cancer

2004 • 44 citations

Cost-Effectiveness Analysis of a Quadrivalent Human Papilloma Virus Vaccine in Mexico

2009 • 43 citations

Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females

2011 • 40 citations

Brachial plexus neuritis following HPV vaccination

2008 • 40 citations

The HPV Vaccine: Science, Ethics and Regulation

2010 • 36 citations

Too Fast or Not Too Fast: The FDA's Approval of Merck's HPV Vaccine Gardasil

2012 • 36 citations

Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girl

2011 • 31 citations

Multiple Evanescent White Dot Syndrome After Vaccination for Human Papilloma Virus and Meningococcus

2009 • 29 citations

Impact of Improved Classification on the Association of Human Papillomavirus With Cervical Precancer

2009 • 28 citations

Trastornos neurológicos desmielinizantes y vacunación del papilomavirus humano

2011 • 26 citations

God's Gift to Women: The Human Papillomavirus Vaccine

2006 • 21 citations

Acute disseminated encephalomyelitis with tumefactive lesions after vaccination against human papillomavirus

2010 • 21 citations

Health technology assessments: what do differing conclusions tell us?

2010 • 13 citations

Cervical Cancer Vaccine

2006 • 12 citations